Verified factor-similar pair

FAD vs FNY

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB UMD
Similarity score
91
Near substitute

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • FAD has the higher backtested relative Sharpe (1.014 vs 0.943).
  • FAD has the lower published fee (0.63% vs 0.73%).
  • FNY is cheaper on dividend valuation (128 vs 446, where 100 is each fund's historical median).
  • FAD has the stronger regression fit (adjusted R-squared 0.935 vs 0.921).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

FAD

First Trust Multi Cap Growth AlphaDEX Fund
SMB UMD
Adj. R2
0.935
Rel. Sharpe
1.014
Mkt beta
1.06
AUM
US$421M
MER
0.63%
Valuation
446

FNY

First Trust Mid Cap Growth AlphaDEX Fund
SMB UMD
Adj. R2
0.921
Rel. Sharpe
0.943
Mkt beta
1.07
AUM
US$486M
MER
0.73%
Valuation
128

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
FAD
+0.48
|t|
+12.2
FNY
+0.59
|t|
+11.7
diff -0.11
HML
FAD
-0.13
|t|
-3.4
FNY
-0.09
|t|
-1.8
diff -0.05
RMW
FAD
-0.04
|t|
-0.8
FNY
-0.04
|t|
-0.7
diff -0.00
CMA
FAD
-0.03
|t|
-0.5
FNY
-0.03
|t|
-0.4
diff -0.00
UMD
FAD
+0.19
|t|
+8.4
FNY
+0.25
|t|
+7.1
diff -0.06

Why This Pair Matches

Exposure level
89
Exposure shape
100
Mkt beta diff
0.01
Rel. Sharpe diff
0.071

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

FAD fund page FNY fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.